What to know about ACIP's vote on hepatitis B vaccine
-
By
-
Laura Ungar
-
Mike Stobbe
-
December 3, 2025
-
Objective:
To summarize the recent changes in hepatitis B vaccination guidelines by the ACIP and the implications of these changes.
Key Findings:
- Hepatitis B can lead to chronic infections, liver failure, and cancer, especially in infants.
- The ACIP's new recommendation allows parents to decide on vaccination timing, which could lead to increased infections.
- Delaying the vaccine could result in an estimated 1,400 additional infections and 480 deaths among children.
Interpretation:
The ACIP's decision may undermine decades of public health success in reducing hepatitis B infections among children.
Limitations:
- The report estimating potential infections and deaths has not yet been peer-reviewed.
- State and local health officials may not follow the new guidelines, leading to inconsistencies in vaccination practices.
Conclusion:
The ACIP's decision has sparked significant concern among health professionals, who fear it could reverse progress in hepatitis B prevention.